| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032743 |
| Receipt No. | R000037344 |
| Scientific Title | A verification study of the influence for cognitive and physical functions by using the sanitary products four consecutive weeks |
| Date of disclosure of the study information | 2018/05/30 |
| Last modified on | 2020/10/09 (Ver. 4) |
| Basic information | ||
| Public title | A verification study of the influence for cognitive and physical functions by using the sanitary products four consecutive weeks | |
| Acronym | A verification study of the influence for cognitive and physical functions by using the sanitary products four consecutive weeks | |
| Scientific Title | A verification study of the influence for cognitive and physical functions by using the sanitary products four consecutive weeks | |
| Scientific Title:Acronym | A verification study of the influence for cognitive and physical functions by using the sanitary products four consecutive weeks | |
| Region |
|
|
| Condition | ||
| Condition | Not applicable | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the influence on cognitive and physical functions by using the sanitary products those are suitable for individual subjects for four consecutive weeks. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (1)Evaluation of cognitive function
(2)Evaluation of physical function |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | During 4 weeks of first term, using sample products (one of pants type or napkin type). Then visit the clinic, answer the questionnaires and questions, measurement of central nervous system and physical functions. During 4 weeks of second term, using control products. Then visit the clinic, answer the questionnaires and questions, measurement of central nervous system and physical functions. | |
| Interventions/Control_2 | During 4 weeks of first term, using control products. Then visit the clinic, answer the questionnaires and questions, measurement of central nervous system and physical functions. During 4 weeks of second term, using sample products (one of pants type or napkin type). Then visit the clinic, answer the questionnaires and questions, measurement of central nervous system and physical functions. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Male and Females aged over 20 years old when informed consent.
(2) Subjects who are usually using or have experience of using the sanitary products such as pad for light incontinence or adult diapers. (3) Even whether using or not sanitary products, subjects who dirty their wear and/or underwear due to incontinence or subjects who have had incontinence symptoms before. (4) Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study. |
|||
| Key exclusion criteria | (1)Subjects who have been determined ineligible by the investigator of this clinical test. | |||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba
School of Integrative |
||||||
| Division name | Global Majors | ||||||
| Zip code | 305-8577 | ||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577 Japan | ||||||
| TEL | 029-853-7344 | ||||||
| yada.yukihiri.gb@u.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | CPCC Company Limited | ||||||
| Division name | Planning & Sales Department | ||||||
| Zip code | 101-0047 | ||||||
| Address | 4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN | ||||||
| TEL | 03-5297-3112 | ||||||
| Homepage URL | |||||||
| cpcc-contact@cpcc.co.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba
School of Integrative |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
| Address | 2F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN |
| Tel | 03-5297-5548 |
| IRB@cpcc.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037344 |